This toolkit was created to educate the public about evidence-based drug policy, increase media interest in drug policy reform and build political support by getting local and national governments to endorse the Vienna Declaration and join the call for evidence-based drug policy.
The three resolutions adopted at this year's CND on 'civil society inclusion', 'promoting rehabilitation and reintegration-oriented strategies' and 'improving access to controlled substances for medical and scientific purposes' provide a great opportunity to take forward the Declaration and Resolutions adopted by consensus at Beyond 2008. This document provides guidance for NGOs' advocacy work.
Thirty years into the AIDS epidemic, investments in the AIDS response are yielding results, according to a new report released today by United Nations Secretary-General Ban Ki-moon. The report highlights that the global rate of new HIV infections is declining, treatment access is expanding and the world has made significant strides in reducing HIV transmission from mother to child.
This report documents the good practices in harm reduction programmes in Malaysia and the progress to date in addressing the transmission of HIV among people who use drugs. It highlights and discusses how policies and programmes have addressed this through strong and committed leadership, community participation, sustained partnerships, and multisectoral collaboration and coordination.
Last January, IDPC organised its first drug policy seminar in the Middle East and North Africa region, in collaboration with its local partner, the National Rehabilitation Centre, in order to generate constructive discussions and sgare experience on drug policy, and to discuss the possibility to establish a regional network on drug policy.
The Sessions in this training guide have been designed to support training workshops and provide information for trainers (ideally peer, law enforcement trainers). The 8 Sessions consist of slides, handouts and background information for law enforcement trainees to better understand the role of law enforcement in facilitating improved access to medical opioids.
The role of law enforcement is key – not only as a component of international drug regulation and control systems, but as a facilitator of access to opioid medicines by those in need. This guide is designed to provide instructive information to all levels of law enforcement, particularly narcotics enforcement at the local, state and national levels, corrective services and custodial officers, and drug regulators.
For harm reduction and drug policy organizations that aim to improve the health and welfare of people who use drugs, the insights of drug users themselves are essential to shaping effective programs. Harm Reduction at Work gives the necessary know-how to ensure that both employees who do use drugs and those who don't are treated fairly.
This public health fact sheet describes how naloxone is successfully being used to reverse overdose around the world with no side effects beyond opiate withdrawal, and provides real-life examples of programs that have trained drug users, their families and friends to efficiently identify the signs of overdose, administer naloxone, and often, save lives.
Fifty years on, it is time for a critical reflection on the validity of the Single Convention today: a reinterpretation of its historical significance and an assessment of its aims, its strengths and its weaknesses. This policy briefing analyses the origins and negotiations of the Single Convention, examines the way it broke with the previous drug control system by introducing a more prohibitive ethos, penal obligations, controls on plants and abolition of traditional uses of plants like coca, and concludes that a revision of its outdated provisions is required.
This briefing paper analyses the reasons behind the proposed amendment and the opposing arguments that have been brought forward, and outlines the various options to be considered as the fate of Bolivia’s proposal is determined. Simply rejecting the amendment will not make the issue disappear.
Since its creation in 2007, IDPC has become a dynamic collaborative initiative which has gradually expanded both its membership and activities to influence national and international drug policies and programmes. This is the first IDPC progress report, which aims to highlight IDPC's key activities and successes since its creation four years ago.
